The risk of early occurrence and recurrence of hepatocellular carcinoma in hepatitis C-infected patients treated with direct-acting antivirals with and without pegylated interferon: A Belgian experience-Reference-Cited by-同舟云学术

The risk of early occurrence and recurrence of hepatocellular carcinoma in hepatitis C-infected patients treated with direct-acting antivirals with and without pegylated interferon: A Belgian experience

Published:2017-08-03 Issue:11 Volume:24 Page:976-981
ISSN:1352-0504
Container-title:Journal of Viral Hepatitis
language:en
Short-container-title:J Viral Hepat

Author:

Bielen R.¹²^ORCID,Moreno C.³,Van Vlierberghe H.⁴,Bourgeois S.⁵,Mulkay J.-P.⁶,Vanwolleghem T.⁷,Verlinden W.⁷,Brixco C.⁸,Decaestecker J.⁹¹⁰,de Galocsy C.¹¹,Janssens F.¹⁰¹²,Van Overbeke L.¹³,Van Steenkiste C.⁴¹⁴,D'Heygere F.¹⁰¹⁵,Cool M.¹⁰¹⁶,Wuyckens K.¹²,Nevens F.¹⁰,Robaeys G.¹²¹⁰

Affiliation:

1. Faculty of Medicine and Life sciences; Hasselt University; Hasselt Belgium

2. Department of Gastro-Enterology and Hepatology; Ziekenhuis-Oost Limburg; Genk Belgium

3. Department of Gastro-Enterology and Hepatopancreatology; Erasme Hospital; Brussels Belgium

4. Department of Hepatology and Gastro-Enterology; University Hospitals Gent; Gent Belgium

5. Department of Gastro-Enterology and Hepatology; ZNA Stuivenberg; Antwerp Belgium

6. Department of Gastro-Enterology and Hepatology; Hôpital Saint-Pierre; Brussels Belgium

7. Department of Gastro-Enterology and Hepatology; Antwerp University Hospital; Edegem Belgium

8. Department of Gastroenterology and Digestive Oncology; CHR Citadelle; Liège Belgium

9. Department of Gastro-Enterology and Hepatology; AZ Delta; Roeselare Belgium

10. Department of Gastro-Enterology and Hepatology; University Hospitals KULeuven; Leuven Belgium

11. Department of Gastro-Enterology and Hepatology; Hôpital HIS Bracops; Anderlecht Brussels Belgium

12. Department of Gastro-Enterology and Hepatology; Jessa Hospital; Hasselt Belgium

13. Department of Gastro-Enterology and Hepatology; AZ Sint Maarten; Mechelen Belgium

14. Department of Gastro-Enterology and Hepatology; AZ Maria Middelares; Gent Belgium

15. Department of Gastro-Enterology and Hepatology; AZ Groeninge; Kortrijk Belgium

16. Department of Gastro-Enterology and Hepatology; AZ Damiaan; Oostende Belgium

Publisher

Wiley

Subject

Virology,Infectious Diseases,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jvh.12726/fullpdf

Reference41 articles.

1. Prognosis of chronic hepatitis C: results of a large, prospective cohort study;Niederau;Hepatology,1998

2. Hepatitis C virus related cirrhosis: time to occurrence of hepatocellular carcinoma and death;Degos;Gut,2000

3. Effect of sustained virological response on long-term clinical outcome in 113 patients with compensated hepatitis C-related cirrhosis treated by interferon alpha and ribavirin;Braks;World J Gastroenterol,2007

4. Hepatitis C virus genotype 1b as a major risk factor associated with hepatocellular carcinoma in patients with cirrhosis: a seventeen-year prospective cohort study;Bruno;Hepatology,2007

5. Impact of peginterferon and ribavirin therapy on hepatocellular carcinoma: incidence and survival in hepatitis C patients with advanced fibrosis;Cardoso;J Hepatol,2010

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Controversies of Direct-Acting Antivirals in Hepatocellular Carcinoma;Surgical Oncology Clinics of North America;2024-01

2. Associations of ITPA gene polymorphisms with outcomes among chronic hepatitis C patients treated with Peg-interferon/ribavirin: A 5-year follow-up study;Medicine;2023-10-27

3. The Cyclophilin Inhibitor Rencofilstat Decreases HCV-Induced Hepatocellular Carcinoma Independently of Its Antiviral Activity;Viruses;2023-10-17

4. Study of gut microbial homeostasis and targeted therapy for hepatocellular carcinoma based on eigenvalue-fitting superiority algorithm;Applied Mathematics and Nonlinear Sciences;2023-10-15

5. The Cyclophilin Inhibitor Rencofilstat Decreases HCV-induced Hepatocellular Carcinoma Independently of Its Antiviral Activity;2023-08-20